Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China flag China · Delayed Price · Currency is CNY
16.80
-0.49 (-2.83%)
Nov 17, 2026, 3:00 PM CST

Aurisco Pharmaceutical Revenue

Aurisco Pharmaceutical had revenue of 385.61M CNY in the quarter ending September 30, 2026, a decrease of -7.10%. This brings the company's total for the last twelve months to 1.67B, up 3.07% year-over-year. In the year 2025, Aurisco Pharmaceutical had annual revenue of 1.70B with 15.03% growth. That makes Aurisco Pharmaceutical the 15,843rd largest company in the world by revenue and 2,863rd in China.

Revenue (ttm)
1.67B
Revenue Growth
+3.07%
P/S Ratio
4.08
Revenue / Employee
826.46K
Employees
2,026
Market Cap
6.78B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Sales of active pharmaceutical ingredients and Intermediates 1.47B 86.5%
  • Sale of Drug Product 184.40M 10.9%
  • Trading of active pharmaceutical ingredients and intermediates 36.00M 2.1%
  • Others 8.73M 0.5%

By Geography

Chart
  • Overseas 1.35B 79.6%
  • China 345.96M 20.4%
Fiscal year ended Dec 31, 2025 See the full Aurisco Pharmaceutical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.70B221.74M15.03%
Dec 31, 20241.48B213.21M16.89%
Dec 31, 20231.26B254.45M25.24%
Dec 31, 20221.01B204.71M25.48%
Dec 31, 2021803.36M81.92M11.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.